Physician profile
Prathab Devaraj
NPI 1073778064
$3,490.90
in general payments reported to CMS, 2019-2025
10 companies · $1,052 in 2025
The $1,052 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $693 · 2022: $444 · 2023: $684 · 2024: $618 · 2025: $1,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,528 · Food and Beverage: $826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,527.52 |
| Food and Beverage | $826.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,406.46 | 2019-2025 | Orise, Resolution 360 Clip, Overstitch Endoscopic Suturing System |
| Ovesco Endoscopy USA, INC. | $698.42 | 2025 | |
| Olympus Corporation of The Americas | $544.17 | 2019 | |
| Creo Medical INC. | $373.96 | 2024 | Speedboat Ultraslim (Sb1l) |
| Medtronic, INC. | $153.96 | 2025 | Nexpowder, Endoflip, Barrx |
| Cook Medical LLC | $137.12 | 2025 | Echotip Insight |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Gilead Sciences, INC. | $20.60 | 2019 | |
| Mauna Kea Technologies, INC. | $17.80 | 2025 | |
| Astellas Pharma US INC | $13.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prathab Devaraj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.